Ignite Creation Date:
2025-12-25 @ 4:13 AM
Ignite Modification Date:
2026-02-25 @ 4:15 AM
Study NCT ID:
NCT02226120
Status:
COMPLETED
Last Update Posted:
2019-02-20
First Post:
2014-08-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Tolerability During Open-label Treatment With LCZ696 in Patients With CHF and Reduced Ejection Fraction
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-10-16
Start Date Type:
ACTUAL
Primary Completion Date:
2017-12-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-12-28
Completion Date Type:
ACTUAL
First Submit Date:
2014-08-25
First Submit QC Date:
None
Study First Post Date:
2014-08-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-12-18
Results First Submit QC Date:
None
Results First Post Date:
2019-02-20
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-02-19
Last Update Post Date:
2019-02-20
Last Update Post Date Type:
ACTUAL